Researchers at Rutgers University-New Brunswick have been studying a fat-regulating enzyme—one they claim could help unlock the science behind obesity, cancer and diabetes.

Dangerous side effects of high blood pressure, including organ damage, could be affecting Americans earlier in life than previously thought, according to a new study published in Hypertension.

Preeclampsia could have a permanent, constricting effect on blood vessels of women who experience the hypertensive condition while pregnant, new research suggests.

Most of us might equate type 2 diabetes with too much sugar, but a recent Swedish study found that risk of developing diabetes correlated to salt intake in the country’s population.

Overtreatment of diabetes in elderly patients could be contributing to an increase in the number of falls, dizzy spells and confusion those individuals experience, according to research published in the Journal of General Internal Medicine.

A 25-year study of young adults transitioning to middle age revealed maintaining a healthy weight was more important in blood pressure control than four other health behaviors.

Amgen (NASDAQ:AMGN) today announced that a new analysis of the cardiovascular outcomes study (FOURIER) demonstrated that lowering low-density lipoprotein cholesterol (LDL-C) levels with Repatha® (evolocumab) significantly and consistently reduced cardiovascular events in patients with and without diabetes at baseline.

September 14, 2017 — A global team of researchers reported in the New England Journal of Medicine that the study did not meet its primary efficacy endpoint, but yielded important results for all-cause mortality.